BioCentury
ARTICLE | Clinical News

Geodon ziprasidone regulatory update

February 2, 2015 8:00 AM UTC

Geodon is approved in the U.S. to treat schizophrenia, for acute treatment of bipolar manic or mixed episodes, for maintenance treatment of bipolar disorder and for acute agitation in schizophrenic pa...